Position in ACET
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$119,024
+$22,002 QoQ
Shares Held
13,776
-3.3% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 56 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $98,796,822 across 44 Biotechnology names. ACET ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,525 | $40,495,910 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33,169 | $20,682,197 | |
| 3 | MRNA |
Moderna, Inc.
|
87,541 | $6,130,496 | |
| 4 | BNTX |
BioNTech SE
|
61,238 | $5,698,195 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
153,242 | $4,018,005 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
35,363 | $2,633,836 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
40,000 | $2,517,600 | |
| 8 | SLS |
SELLAS Life Sciences Group, Inc.
|
146,762 | $2,166,207 |
All Filings in ACET
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,024 | 13,776 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $97,022 | 14,247 | Shares | Defined | 2026-05-08 | |
| 2025-09-30 | $64,800 | 80,000 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $48,800 | 80,000 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $45,300 | 60,000 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $48,100 | 50,000 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $57,600 | 40,000 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $48,400 | 40,000 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $63,450 | 27,000 | Shares | Defined | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||